Phibro Animal Health Corporation (PAHC) Earnings History
Steady Earner26 years of earnings data (2000–2025) · Positive but moderate multi-year EPS trajectory
Loading earnings history...
Phibro Animal Health Corporation (PAHC) Earnings Overview
As of June 22, 2026, Phibro Animal Health Corporation (PAHC) reported trailing twelve-month net income of $92M, reflecting +1883.3% year-over-year growth. The company earned $2.25 per diluted share over the past four quarters, with a net profit margin of 3.7%.
Looking at the long-term picture, PAHC's 5-year EPS compound annual growth rate (CAGR) stands at +7.5%, showing solid earnings momentum. The company achieved its highest annual net income of $83M in fiscal 2016.
Phibro Animal Health Corporation maintains positive profitability with a gross margin of 30.9%, operating margin of 8.5%, and net margin of 3.7%. The company continues to generate positive earnings from operations. View revenue history →
Compared to peers including ELAN (-$242M net income, -4.9% margin), ZTS ($2.64B net income, 28.2% margin), NEOG (-$603M net income, -122.1% margin), PAHC has outperformed on profitability metrics. Compare PAHC vs ELAN →
PAHC Earnings vs Peers
Earnings metrics vs comparable public companies
PAHC Historical Earnings Data (2000–2025)
22 years| Fiscal Year | Net Income | YoY % | Operating Income | EPS (Diluted) | Net Margin | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $48M | +1897.7% | $110M | $1.19 | 3.7% | 8.5% |
| 2024 | $2M | -92.6% | $53M | $0.06 | 0.2% | 5.2% |
| 2023 | $33M | -33.7% | $72M | $0.81 | 3.3% | 7.3% |
| 2022 | $49M | -9.6% | $79M | $1.21 | 5.2% | 8.4% |
| 2021 | $54M | +62.1% | $75M | $1.34 | 6.5% | 9.0% |
| 2020 | $34M | -38.7% | $69M | $0.83 | 4.2% | 8.6% |
| 2019 | $55M | -15.7% | $73M | $1.35 | 6.6% | 8.9% |
| 2018 | $65M | +0.5% | $99M | $1.61 | 7.9% | 12.1% |
| 2017 | $65M | -21.9% | $98M | $1.61 | 8.5% | 12.8% |
| 2016 | $83M | +37.2% | $86M | $2.07 | 11.0% | 11.4% |
| 2015 | $60M | +2044.5% | $88M | $1.51 | 8.1% | 11.7% |
| 2014 | -$3M | -112.5% | $64M | $-0.10 | -0.4% | 9.2% |
| 2013 | $25M | +256.8% | $57M | $0.82 | 3.8% | 8.7% |
| 2012 | $7M | +204.1% | $49M | $0.23 | 1.1% | 7.5% |
| 2007 | -$7M | +48.9% | $21M | $-0.17 | -1.5% | 4.7% |
| 2006 | -$13M | +40.7% | $23M | $-0.22 | -3.3% | 5.8% |
| 2005 | -$22M | -271.3% | $4M | $-0.37 | -6.1% | 1.2% |
| 2004 | $13M | +173.3% | $44M | $0.22 | 3.6% | 12.3% |
| 2003 | -$18M | +66.0% | $26M | $-0.29 | -5.2% | 7.7% |
| 2002 | -$52M | -247.7% | $11M | $-0.86 | -15.8% | 3.2% |
| 2001 | -$15M | -247.5% | $5M | $-0.25 | -4.7% | 1.7% |
| 2000 | $10M | - | $16M | $0.17 | 3.1% | 4.9% |
Download Data
Export PAHC earnings history in CSV or JSON format
Free sign-in required to download data
Intrinsic Valuation
DCF models, multiple analysis, and analyst estimates.
Historical Returns
26+ years return with dividends reinvested.
DCA Calculator
See how regular investing compounds over time.
Peer Comparison
Compare growth, multiples, and margins vs sector.
PAHC — Frequently Asked Questions
Quick answers to the most common questions about buying PAHC stock.
What is PAHC earnings per share (EPS)?
PAHC trailing twelve-month (TTM) diluted EPS is $2.25, reflecting +1883.3% year-over-year growth. The 5-year EPS CAGR is +7.5%. Complete EPS history from 2000 to 2025 is available in the table on this page.
What is Phibro Animal Health Corporation's net income?
Phibro Animal Health Corporation (PAHC) trailing twelve-month net income is $92M as of 2025. Earnings grew +1883.3% year-over-year. Phibro Animal Health Corporation has been profitable for 11 consecutive years.
Is PAHC profitable?
Yes, PAHC is profitable with a TTM net income of $92M and a net profit margin of +3.7%. Phibro Animal Health Corporation has generated profits for 11 consecutive years.
What is PAHC's earnings growth rate?
PAHC compound annual EPS growth rates (CAGR): 1-Year: +1883.3%, 3-Year: -0.6%, 5-Year: +7.5%, 10-Year: -2.4%. These figures measure the annualised rate of diluted EPS growth over each period, based on data from 2000 to 2025.
What are PAHC's profit margins?
Phibro Animal Health Corporation net profit margin is +3.7%, operating margin is +8.5%, and gross margin is +30.9%. Below-average margins reflect competitive or cost pressures. Return on Equity is +17.8%.
Is PAHC growing earnings?
Yes, PAHC earnings are accelerating — EPS growth of +1883.3% exceeds the 5-year CAGR of +7.5%. TTM net income reached $92M. Earnings momentum is strengthening.
What was PAHC's best earnings year?
Phibro Animal Health Corporation's highest annual net income on record is $83M, achieved in fiscal year 2016. Earnings history on this page spans 2000 to 2025 and includes all annual and quarterly figures.
What were PAHC's earnings last quarter?
PAHC's most recent reported quarter was Q2 2026. Net income was $27M with diluted EPS of $0.67. For a full breakdown of all quarters, see the quarterly earnings table on this page.